Updates are available Correction dated 2023-06-19

Article History

Received: 26 April 2019

Revised: 21 September 2019

Accepted: 23 October 2019

First Online: 19 November 2019

Change Date: 19 June 2023

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.1038/s41416-023-02305-y

Competing interests

: The authors declare no competing interests.

: Clinical tissue samples were purchased from Chaoying Biotechnology Co., Ltd. (Xian, China), and the research was approved by the Medical Ethics Committee of Tongxu County People’s Hospital of Henan Province. The approval of the Ethics Committee of Tongxu County People’s Hospital in Henan Province has stated that all participants have informed consent and that their privacy has been fully protected. All animal experiments were authorised through the Animal Care and Use Committee of Southwest University. All animal experiments were conducted in accordance with the Guidelines for Animal Health and Use (Ministry of Science and Technology of China, 2006). Human GBM cell lines (LN229, U87MG, A172 and U118) and normal astrocytes (SVGP12) were obtained from American Type Culture Collection.

: This research was supported by funds from the National Natural Science Foundation of China (No. 81872071, 81672502). The funder did not contribute to the experimental design, the experimental processes and data processing, the writing of the paper and the delivery or the publication of this paper reporting this study.

: All the data analysed or generated in this study are included in this article and its Supplementary Information file.